Trials / Completed
CompletedNCT02658448
GTx-024 as a Treatment for Stress Urinary Incontinence in Women
GTx-024 as a Treatment for Stress Urinary Incontinence in Women: A Proof of Concept Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- GTx · Industry
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether GTx-024 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GTx-024 | GTx-024 softgel capsules will be administered once-daily to a total dose of 3 mg |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2016-01-18
- Last updated
- 2021-02-01
- Results posted
- 2021-02-01
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02658448. Inclusion in this directory is not an endorsement.